Asthma
Our group has three main lines of research: 1. Developing new
therapeutic approaches for asthma, in particular, to develop monoclonal
antibodies as therapeutic tools; 2. Studying the link between diet,
fatty acid binding proteins and asthma; 3. Looking more broadly at the
links between inflammatory and metabolic diseases because we now know
that inflammatory cells release signalling molecules called cytokines
that can affect various aspects of metabolism.
N.B. Garvan's Asthma Research Group is part of the CRC for Asthma and Airways
News
Garvan immunology students win main prizes at ASI conference
19 Dec 2008
For the second year in a row, a PhD student from Garvan has won the very prestigious New Investigator Award at the annual Australasian Society for Immunology (ASI) conference, held last week in Canberra. The 2008 winner is Alexis Vogelzang.
Sydney scientists discover & license breakthrough anti-inflammatory treatment
08 Feb 2006
Scientists from the Garvan Institute of Medical Research have developed what could be the next big blockbuster treatment for inflammatory diseases such as rheumatoid arthritis and asthma.
